User menu

Ganciclovir mediated regression of rat brain tumors expressing the herpes simplex virus thymidine kinase imaged by magnetic resonance.

Bibliographic reference Maron, A ; Gustin, Thierry ; Mottet, I. ; Demeure, R. ; Octave, Jean-Noël. Ganciclovir mediated regression of rat brain tumors expressing the herpes simplex virus thymidine kinase imaged by magnetic resonance.. In: Journal of neuro-oncology, Vol. 24, no. 3, p. 259-65 (1995)
Permanent URL
  1. Schoenberg BS: The epidemiology of nervous system tumors. In: Oncology of the Nervous System, MD Walker (eds). Martinus Nijhoff Publishers, Boston, 1983, pp 1?30
  2. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytomas: a simple and reproductible method. Cancer 62: 2152?2165, 1988
  3. Mahaley MS, Mettlin C, Natarajan N, Laws ER Jr, Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826?836, 1989
  4. Itaya T, Yamagiwa S, Okada F, Oikawa T, Kuzumaki N, Takeichi N, Hosokawa M, Kobayashi H: Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogenic class I major histocompatibility complex gene (H-2Ld). Cancer Res 47: 3136?3140, 1987
  5. Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P: Interleu-kin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397?403, 1990
  6. Tepper RI, Pattengale PK, Leder P: Murine interleukin-4 potent anti-tumor activityin vivo. Cell 57: 503?512, 1989
  7. Wei MX, Hurford RK Jr, Tepper RI, Breakefield XO, Chiocca EA: Genetic treatment of intracerebral rodent brain tumors with an interleukin-4 retrovirus vector (Abstract). Soc Neurosci 19: 1071, 1993
  8. Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E: Retroviral vector-mediated ?-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50: 7820?7825, 1990
  9. Ram Z, Walbridge S, Heiss JD, Culver KW, Blaese RM, Oldfield EH:In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. J Neurosurg 80: 535?54, 1994
  10. Austin EA, Huber BE: A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharm 43: 380?387, 1993
  11. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D: Regression of established macroscopic liver metastases afterin situ transduction of a suicide gene. Proc Natl Acad Sci USA 90: 7024?7028, 1993
  12. Moolten FL: Tumor chemosensitivity conferred by inserted Herpes simplex thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46: 5276?5281, 1986
  13. Moolten FL, Wells JM: Curability of tumors bearing Herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82: 297?300, 1990
  14. Moolten FL, Wells JM, Heyman RA, Evans RM: Lymphoma regression induced by ganciclovir in mice bearing a Herpes thymidine kinase transgene. Hum Gene Ther 1: 125?134, 1990
  15. Mullen CA, Kilstrup M, Blaese RM: Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA 89: 33?37, 1992
  16. Barba D, Hardin J, Ray J, Gage FH: Thymidine kinase-me-diated killing of rat brain tumors. J Neurosurg 79: 729?735, 1993
  17. Barba D, Hardin J, Sadelain M, Gage FH: Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 91: 4348?4352, 1994
  18. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SLC: Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transferin vivo. Proc Natl Acad Sci USA 91: 3054?3057, 1994
  19. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM:In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550?1552, 1992
  20. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH:In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83?88, 1993
  21. Colbere-Garapin F, Chousterman S, Horodniceanu F, Kourilsky P, Garapin AC: Cloning of the active thymidine kinase gene of Herpes simplex virus type 1 in Escherichia coli K12. Proc Natl Acad Sci USA 76: 3755?3758, 1979
  22. Chen C, Okayoma H: Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6: 632?638, 1988
  23. Benabid AL, Remy C, Chauvin C: Experimental models of rat brain tumors by stereotactic injection of C6 glioma and HTC hepatoma cell lines. In: Walker MD (eds) Biology of Brain Tumor, Martinus Nijhoff Publishers, Boston, pp 221?226, 1986
  24. Kobayashi N, Allen N, Clendenon NR, Ko LW: An improved rat brain-tumor model. J Neurosurg 53: 808?815, 1980
  25. Ezzedine ZD, Martuza RL, Platika D, Short MP, Malick A, Choi B, Breakefield XO: Selective killing of glioma cells in culture andin vivo by retrovirus transfer of the Herpes simplex virus thymidine kinase gene. New Biol 3: 608?614, 1991
  26. Takamiya Y, Short MP, Ezzedine ZD, Moolten FL, Breake-field XO, Martuza RL: Gene therapy of malignant brain tumors: a rat glioma line bearing the Herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 33: 493?503, 1992
  27. Takamiya Y, Short MP, Moolten FL, Fleet C, Mineta T, Breakefield XO, Martuza RL: An experimental model of retrovirus gene therapy for malignant brain tumors. J Neurosurg 79: 104?110, 1993